Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design-Reference-Cited by-同舟云学术

Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design

Published:2022-01-12 Issue:3 Volume:45 Page:299-307
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clinical Cardiology

Author:

Chi Gerald¹^ORCID,Lee Jane J.²,Kazmi Syed H. A.¹,Fitzgerald Clara¹,Memar Montazerin Sahar¹,Kalayci Arzu¹,Korjian Serge¹,Heise Mark³,Deckelbaum Lawrence I.³,Libby Peter⁴,Bhatt Deepak L.⁴,Gibson C. Michael¹

Affiliation:

1. Department of Medicine, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA

2. Baim Institute for Clinical Research Boston Massachusetts USA

3. CSL Behring King of Prussia Pennsylvania USA

4. Division of Cardiovascular Medicine, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

Funder

CSL Behring

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23773

Reference23 articles.

1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy SM;Circulation,2019

2. Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

3. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

4. Comparative evaluation of the reliability and validity of three data extraction programs: UnGraph, GraphClick, and DigitizeIt

5. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning models for predicting risks of MACEs for myocardial infarction patients with different VEGFR2 genotypes;Frontiers in Medicine;2024-09-05

2. Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early vascular events after acute myocardial infarction;European Heart Journal;2024-07-26

3. Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study;Journal of Clinical Lipidology;2024-06

4. CSL112 (Apolipoprotein A‐I [Human]) Reduces the Elevation in Neutrophil‐to‐Lymphocyte Ratio Induced by Acute Myocardial Infarction;Journal of the American Heart Association;2024-05-07

5. Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction;New England Journal of Medicine;2024-05-02